IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1254
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$19M
Alfredo Bala
Mannatech, Incorporated sells nutritional supplements, topical and skin care, and anti-aging products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech was founded in 1993 and is headquartered in Flower Mound, Texas.
Headcount
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = MTEX ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$MTEX MANNATECH INC | 55 | 86 | 81 | 19 | 6.9x | 17.9x | -8.0% | -1.7% | 75.5% | 0.6% | -0.6% | -0.8% | 0.0% | 42.0x | $19M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
MANNATECH INC (MTEX) receives a "Hold" rating with a composite score of 55.1/100. It ranks #1254 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Alfredo Bala
Chief Executive Officer
Labor Force
250
86
36
59
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for MTEX
250
HQ Base
COPPELL, Texas
Lagging peers — losers tend to keep underperforming
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Average volatility — neutral timing signal
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for MTEX.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 86 | 98 | -12DRAG |
| MOMENTUM | 19 | 3 | +16ALPHA |
| VALUATION | 81 | 81 | 0NEUTRAL |
| INVESTMENT | 36 | 59 | -23DRAG |
| STABILITY | 59 | 49 | +10ALPHA |
| SHORT INT | 62 | 72 | -10DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -8.0% (sector -2.5%)
GM 76% vs sector 43%, OM 1% vs sector 1%
Capital turnover N/A
Rev growth -1%, 10yr history
Interest coverage 19.3x, Net debt/EBITDA -2.1x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns MANNATECH INC a Hold rating, with a composite score of 55.1/100 and 3 out of 5 stars. Ranked #1254 of 7,333 stocks, MTEX presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
MANNATECH INC scores an outstanding 86/100 on our quality factor, placing it among the highest-quality companies in our coverage universe. The company reports a return on equity of -8.0% (sector avg: -2.5%), gross margins of 75.5% (sector avg: 42.5%), net margins of -0.6% (sector avg: -0.2%). This level of profitability and capital efficiency typically reflects a durable competitive advantage and disciplined management.
MTEX carries a solid value score of 81/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 6.93x, an EV/EBITDA of 17.94x, a P/B ratio of 1.95x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
MANNATECH INC's investment score of 36/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -0.8% vs. a sector average of 5.9% and a return on assets of -1.7% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
MANNATECH INC is experiencing notably weak momentum with a score of just 19/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -0.8% year-over-year, while a beta of 0.68 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
With a stability score of 59/100, MTEX exhibits average financial resilience. Key stability metrics include a beta of 0.68 and a debt-to-equity ratio of 42.00x (sector avg: 0.2x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
MTEX carries a short interest score of 62/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 42.00x), micro-cap liquidity risk. At $19M market cap (micro-cap), MANNATECH INC offers reasonable institutional liquidity.
MANNATECH INC is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1254 of 7,333 overall (83rd percentile). Key comparisons include ROE of -8.0% trailing the -2.5% sector median and operating margins of 0.6% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While MTEX currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Quality (86) vs Momentum (19) — closing this gap could shift the rating.
EV/EBITDA 57% ABOVE SECTOR MEDIAN
ROE 224% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 78% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate MANNATECH INC (MTEX) as a Hold with a composite score of 55.1/100 at a current price of $7.00. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in quality (86th percentile) and value (81th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (19th percentile) and investment (36th percentile) tempers our overall conviction. We assign a No Moat rating (38/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
MANNATECH INC holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 55.1/100 places it at rank #1254 in our full 7,333-stock universe. At $19M in market capitalization, MANNATECH INC is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -1% combined with momentum at the 19th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 76% (+33.0pp vs sector) narrow to operating margins of 1% (-0.7pp vs sector) and net margins of -0.6%, yielding a gross-to-net conversion rate of -1%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $7.00, MANNATECH INC appears undervalued relative to its fundamentals. Our value factor score of 81/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 6.9x (a 69% discount to the sector median of 22.3x), EV/EBITDA of 17.9x (at a premium), P/B of 1.9x, P/S of 0.1x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Gross margins of 76% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
A value factor score of 81/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Revenue decline of -1% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -0.6% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Weak momentum (19th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
We assign a Medium uncertainty rating to MANNATECH INC. The stock presents a balanced risk profile: current negative profitability (net margin -0.6%) and low beta of 0.68 — while defensive, this may indicate limited upside participation in bull markets. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: current negative profitability (net margin -0.6%); low beta of 0.68 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 59th percentile and quality factor at the 86th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 76% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate MANNATECH INC's capital allocation as Poor. Key concerns include low returns on equity (-8.0%), negative profitability, weak asset returns (ROA -1.7%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — MANNATECH INC significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, MANNATECH INC receives a Hold rating with a composite score of 55.1/100 (rank #1254 of 7,333). Our quantitative framework assigns a No Moat (38/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 56/100.
Our analysis supports a neutral stance on MANNATECH INC. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign MANNATECH INC a meaningful economic moat, scoring 38/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, financial resilience, reached only 18.3/20.
The strongest moat sources are financial resilience (18.3/20) and margin superiority (15.9/20). Interest coverage 19.3x, Net debt/EBITDA -2.1x. GM 76% vs sector 43%, OM 1% vs sector 1%. These pillars form the core of MANNATECH INC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and economic value creation (1.7/20). Capital turnover N/A. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect MANNATECH INC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 76% providing a solid profitability foundation, declining revenues (-1%) that pressure the earnings outlook. The margin cascade from 76% gross to 1% operating to -0.6% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 86th percentile.
The margin profile shows gross margins of 76%, operating margins of 1%, net margins of -0.6%. Return metrics include ROE of -8.0% and ROA of -1.7%. Relative to the Manufacturing sector, gross margins are 33.0 percentage points above the sector median of 43%, and ROE of -8.0% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 42%, revenue growth of -1%. The sector median D/E is 0%, putting MANNATECH INC at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.

Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. Molecular Templates, Inc. (NASDAQ: MTEM) rose 29.7% to $0.61. Molecular Templates received FDA clearance to proceed for clinical testing of its novel MT-8421 ETB program. Jeffs' Brands Ltd (NASDAQ: JFBR) gained 23% to $1.7110. Jeffs' Brands recently entered into a definitive agreement to acquire the entire share capital of Fort Products Ltd for $1.92 million. PLAYSTUDIOS, Inc. (NASDAQ: MYPS) gained 20.5% to $4.1814 after reporting upbeat quarterly results. Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares rose 19.7% to $2.47 after jumping 27% on Thursday. The company recently announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. PlayAGS, Inc. (NYSE: AGS) shares gained 18.3% to $7.51 after the company posted better-than-expected Q4 results. Mannatech, Incorporated (NASDAQ: MTEX) rose 18.2% to $21.00. Heritage Global Inc. (NASDAQ: HGBL) shares climbed 16.6% to $2.8799 after the company reported strong Q4 financial results. View, Inc. (NASDAQ: VIEW) rose 16% to $0.6596. View is expected to report Q4 financial results after the market close on March 29, 2023. Riskified Ltd. (NYSE: RSKD) gained 14.7% to $6.17. Piper Sandler upgraded Riskified from Neutral to Overweight and raised the price target from $6 to $8. MamaMancini's Holdings, Inc. (NASDAQ: MMMB) gained 13.6% to $1.60. Intuitive Machines, Inc. (NASDAQ: LUNR) rose 12.4% to $18.21 after gaining around 58% on Thursday. Bird Global, Inc. (NASDAQ: BRDS) gained 11.3% to $0.2003 after the company reported better-than-expected Q4 sales results. Theriva Biologics, Inc. (NYSE: TOVX) jumped 11% to $0.82. Silvergate Capital Corporation (NYSE: SI) shares rose 8.6% to $3.0850. Silvergate Capital shares dipped 42% on Thursday after the company announced it will wind down operations and voluntarily liquidate Silvergate Bank. Bon Natural Life Limited ...

Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares climbed 97.5% to close at $4.74 on Monday after the company and Seagen Inc (NASDAQ: SGEN) announced an exclusive license agreement in which Seagen will work to develop, manufacture and commercialize LAVA-1223. DIRTT Environmental Solutions Ltd. (NASDAQ: DRTT) climbed 41% to close at $0.4499. Studio City International Holdings Limited (NYSE: MSC) climbed 36.9% to close at $2.45. Panbela Therapeutics, Inc. (NASDAQ: PBLA) gained 26% to close at $0.3401. Melco Resorts & Entertainment Limited (NASDAQ: MLCO) rose 25.5% to close at $6.65 after Macau officials signaled that COVID-19 travel restrictions will be lifted. Citigroup analyst George Choi also maintained Melco with a Buy rating and raised the price target from $11 to $11.50. Polar Power, Inc. (NASDAQ: POLA) gained 25.4% to settle at $3.16. Alaunos Therapeutics, Inc. (NASDAQ: TCRT) climbed 24.3% to close at $2.15. Pioneer Power Solutions, Inc. (NASDAQ: PPSI) rose 23.5% to close at $3.99. Pioneer Power Solutions, last month, said Q2 EPS results were down year over year. Heliogen, Inc. (NYSE: HLGN) gained 23.2% to close at $1.70. HeartBeam, Inc. (NASDAQ: BEAT) rose 22.2% to settle at $2.48. Inpixon (NASDAQ: INPX) jumped 21.5% to close at $0.1407 after the company announced it signed a definitive merger agreement with KINS Technology for KINS to acquire Inpixon's enterprise apps business. AEA-Bridges Impact Corp. (NYSE: IMPX) gained 20.7% to close at $9.39. FingerMotion, Inc. (NASDAQ: FNGR) gained 19.7% to close at $0.7896. Mannatech, Incorporated (NASDAQ: MTEX) surged 18.4% to close at $22.80. GreenLight Biosciences Holdings (NASDAQ: GRNA) gained 18.2% to settle at $2.27. Pulse Biosciences, Inc. (NASDAQ: PLSE) surged 17.5% to close at $1.81 after the company announced FDA 510(k) clearance for the treatment of sebaceous hyperplasia. MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) climbed 17.1% to close at $2.60. Allied Healthcare Products, Inc. (NASDAQ: AHPI) gained 17.1% to close at $1.71. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 16.2% to settle at $1.87. 374Water, Inc. (NASDAQ: SCWO) gained 15.4% to close at $3.45. Aditxt, Inc. (NASDAQ: ADTX) shares climbed 14.7% to close at $3.05 after amended 13G filing showed a 9.9% stake from Intracoastal Capital LLC. Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) rose 14.1% to settle at $0.5888. SES AI Corporation (NYSE: SES) gained 14.1% to settle at $5.09. Vapotherm, Inc. (NYSE: VAPO) surged 13.9% to close at $1.64. Shift Technologies, Inc. (NASDAQ: SFT) surged 12.7% to settle at $0.7350. Wynn Resorts, Limited (NASDAQ: WYNN) gained 12% to close at $66.80 after Macau officials signaled that COVID-19 travel restrictions will be lifted. Citigroup analyst George Choi also maintained Wynn with a Buy rating and raised the price ...

Gainers SOBR Safe, Inc. (NASDAQ: SOBR) shares surged 232.8% to settle at $3.03 on Tuesday following a report suggesting The National Transportation Safety Board is recommending that NHTSA require passive alcohol-detection systems. The company is engaged in developing alcohol-detecting devices to address the automotive alcohol sensing spectrum. Amprius Technologies, Inc. (NYSE: AMPX) shares jumped 86.4% to close at $11.00 on Tuesday. Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) surged 60.6% to settle at $2.2005. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) gained 42.4% to close at $20.79. Strength may be due to short interest in the stock and social media interest. Virax Biolabs Group Limited (NASDAQ: VRAX) climbed 41.3% to close at $3.49 after the company announced the distribution of a Monkeypox Virus Antigen Rapid Test Kits which has been launched in markets accepting the CE mark, such as the European Union. Cassava Sciences, Inc. (NASDAQ: SAVA) gained 28.4% to close at $38.91. TRxADE HEALTH, Inc. (NASDAQ: MEDS) gained 27.7% to close at $1.36 after the company announced Bonum Health, a subsidiary, signed a Telemedicine Services Distribution Deal with Wakefern Food, to deploy telemedicine services throughout ShopRite pharmacy-led locations in New Jersey, New York, Pennsylvania, Connecticut and Maryland. Mobile Global Esports Inc. (NASDAQ: MGAM) shares climbed 26.5% to close at $3.06 after gaining over 4% on Monday. SaverOne 2014 Ltd (NASDAQ: SVRE) rose 22.4% to close at $2.35. Strauss Frito-Lay chose the SaverOne Protection System for its delivery trucks in Israel. Yunji Inc. (NASDAQ: YJ) gained 20.2% to close at $1.00. bluebird bio, Inc. (NASDAQ: BLUE) jumped 15.7% to close at $6.86. Raymond James maintained bluebird bio with an Outperform and raised the price target from $8 to $10. Renovacor, Inc. (NYSE: RCOR) jumped 14.7% to close at $2.18. Rocket Pharmaceuticals agreed to acquire Renovacor in an all-stock transaction for an implied value of approximately $2.60 per share. Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares gained 14.7% to close at $0.3753 on Tuesday. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million. mCloud Technologies Corp. (NASDAQ: MCLD) rose 14.7% to settle at $2.1561. Troika Media Group, Inc. (NASDAQ: TRKA) surged 14.4% to close at $0.46. D-Wave Quantum Inc. (NYSE: QBTS) gained 14.3% to close at $6.56. Mannatech, Incorporated (NASDAQ: MTEX) climbed 13.4% to settle at $19.85. Mannatech Board of Directors approved a share repurchase program to acquire up to $1.5 million of its outstanding shares. China Liberal Education Holdings Limited (NASDAQ: CLEU) gained 13.3% to close at $0.9150. China Liberal Education Holdings recently signed a letter with Aiways Holdings Limited to acquire all outstanding equity interest of Aiways. Reborn Coffee, Inc. (NASDAQ:

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares gained 80.2% to close at $0.91 after the company announced a marketing authorization application for pegzilarginase for the treatment of Arginase 1 deficiency has been submitted to and successfully validated by the European Medicines Agency. Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA) jumped 48.3% to settle at $14.07 following the completion of the SPAC merger with Akili. Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 40.4% to close at $59.55 after the company announced the U.S. FDA has approved Auvelity for the treatment of major depressive disorder in adults. Lottery.com Inc. (NASDAQ: LTRY) gained 31.8% to settle at $0.48. Volcon, Inc. (NASDAQ: VLCN) rose 31.5% to settle at $2.42 after the company announced it has received over $100 million of pre-production orders for the Stag. Greenbrook TMS Inc. (NASDAQ: GBNH) gained 29.5% to close at $3.07. Greenbrook TMS recently posted Q2 loss of $0.41 per share. Graphex Group Limited (NYSE: GRFX) jumped 21.4% to close at $2.50. Graphex Group announced closing of upsized $11.7 million public offering and NYSE American listing. Immunovant, Inc. (NASDAQ: IMVT) gained 21.1% to settle at $6.21. Foot Locker, Inc. (NYSE: FL) climbed 20% to close at $38.39 after the company reported Q2 results and announced a CEO transition. B of A Securities and Citigroup upgraded their ratings on the stock. T Stamp Inc. (NASDAQ: IDAI) gained 19.9% to settle at $1.75. Aditxt, Inc. (NASDAQ: ADTX) gained 18.5% to settle at $0.19. Assure Holdings Corp. (NASDAQ: IONM) climbed 17.7% to close at $1.40. Assure Hldgs recently posted Q2 loss of $0.37 per share. Bill.com Holdings, Inc. (NYSE: BILL) shares jumped 16.7% to close at $174.29 after the company announced better-than-expected Q4 results and issued sales guidance above estimates. Bionomics Limited (NASDAQ: BNOX) rose 16.2% to close at $8.15. Taylor Devices, Inc. (NASDAQ: TAYD) gained 16.1% to settle at $9.81 after reporting a sharp rise in Q4 earnings. Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 14.2% to close at $4.11. Applied DNA submitted PCR-based Monkeypox virus diagnostic test for approval to New York State Department of Health. Regis Corporation (NYSE: RGS) gained 13.8% to close at $1.57. Mannatech, Incorporated (NASDAQ: MTEX) surged 12.8% to settle at $26.50. Mannatech recently reported a second-quarter FY22 sales decline of 17.7% year-on-year, to $35 million, compared to $42.5 million. Secoo Holding Limited (NASDAQ: SECO) jumped 11.3% to close at $0.2650 following announcement of equity investment led by private equity firm HCYK. Bruush Oral Care Inc. (NASDAQ: BRSH) gained 11.3% to settle at $2.36. Avaya Holdings Corp. (NYSE: AVYA) rose 11.2% to close at $0.7246. Avaya recently received New York Stock Exchange notice regarding late form 10-Q filing. Summit Therapeutics Inc. (NASDAQ: SMMT) shares gained 10% to close at $1.10. Summit Therapeutics CEO Robert W Duggan acquired a total of 94,849,203 shares at an average price of $0.97. Occidental Petroleum Corporation (NYSE: OXY) ...

U.S. stocks closed mostly higher on Thursday. Here is the list of some big stocks moving higher in the previous session. Wolfspeed, Inc. (NYSE: WOLF) shares surged 31.8% to settle at $112.91 after the company reported better-than-expected Q4 EPS and sales results. Additionally, multiple firms raised their price target on the stock. Weber Inc. (NYSE: WEBR) gained 27.2% to close at $10.00. Mannatech, Incorporated (NASDAQ: MTEX) gained 17.1% to close at $23.50. Mannatech recently reported a second-quarter FY22 sales decline of 17.7% year-on-year, to $35 million. Canadian Solar Inc. (NASDAQ: CSIQ) jumped 15.2% to close at $45.19 after the company reported better-than-expected Q2 results and raised Q3 and FY22 sales guidance above estimates. Tellurian Inc. (NASDAQ: TELL) gained 13% ...
Above 50MA
37.18%
Net New Highs
+51081